The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
<p>Muscle invasive bladder cancer (MIBC) has a poor prognosis. Currently, therapy consists of radical radiotherapy or cystectomy with or without chemotherapy. The average age of patients with MIBC is high and older patients are less able to tolerate surgery or chemoradiation due to their impai...
Κύριος συγγραφέας: | Groselj, B |
---|---|
Άλλοι συγγραφείς: | Kiltie, A |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2014
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
ανά: Groselj, B, κ.ά.
Έκδοση: (2013) -
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
ανά: Groselj, B, κ.ά.
Έκδοση: (2013) -
Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
ανά: Groselj, B, κ.ά.
Έκδοση: (2013) -
Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
ανά: Groselj, B, κ.ά.
Έκδοση: (2013) -
Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
ανά: Jennifer Antrobus, κ.ά.
Έκδοση: (2022-03-01)